News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
6,326 Results
Type
Article (56)
Press Release (6270)
Section
Business (2604)
Career Advice (4)
Deals (383)
Drug Development (1318)
FDA (227)
Job Trends (411)
News (4256)
Policy (225)
Tag
Academia (7)
Allergies (4)
Alliances (85)
Alzheimer's disease (41)
Approvals (246)
Artificial intelligence (2)
Bankruptcy (1)
Best Places to Work (463)
Bladder cancer (4)
Breast cancer (8)
Cancer (96)
Cardiovascular disease (3)
Career advice (3)
CAR-T (2)
Cell therapy (4)
Cervical cancer (3)
Clinical research (1296)
Collaboration (6)
Compensation (1)
COVID-19 (10)
CRISPR (1)
Data (119)
Diabetes (5)
Diagnostics (60)
Drug discovery (2)
Drug pricing (1)
Earnings (2701)
Events (635)
Executive appointments (1)
FDA (274)
Frontotemporal dementia (1)
Funding (6)
Gene editing (1)
Generative AI (1)
Gene therapy (7)
GLP-1 (9)
Government (25)
Guidances (3)
Healthcare (167)
Indications (1)
Infectious disease (16)
Inflammatory bowel disease (2)
Influenza (1)
IPO (323)
IRA (1)
Job creations (5)
Job search strategy (3)
Kidney cancer (2)
Layoffs (3)
Legal (10)
Lung cancer (28)
Lymphoma (10)
Manufacturing (1)
MASH (3)
Medical device (202)
Medtech (202)
Mergers & acquisitions (65)
Metabolic disorders (10)
Multiple sclerosis (2)
NASH (2)
Neuroscience (52)
NextGen: Class of 2025 (16)
Non-profit (20)
Northern California (70)
Obesity (3)
Opinion (1)
Pancreatic cancer (1)
Parkinson's disease (5)
Patient recruitment (1)
Peanut (4)
People (29)
Phase I (185)
Phase II (388)
Phase III (755)
Pipeline (70)
Policy (1)
Postmarket research (86)
Preclinical (28)
Prostate cancer (3)
Radiopharmaceuticals (7)
Rare diseases (6)
Real estate (2)
Regulatory (250)
Reports (2)
Research institute (10)
Resumes & cover letters (2)
Rett syndrome (1)
RSV (4)
Schizophrenia (2)
Series B (1)
Sickle cell disease (1)
Southern California (31)
Spinal muscular atrophy (1)
Startups (4)
United States (520)
Vaccines (10)
Date
Last 7 days (5)
Last 30 days (56)
Last 365 days (841)
2025 (250)
2024 (777)
2023 (760)
2022 (807)
2021 (873)
2020 (610)
2019 (414)
2018 (359)
2017 (269)
2016 (132)
2015 (188)
2014 (114)
2013 (69)
2012 (93)
2011 (99)
2010 (92)
Location
Africa (1)
Arizona (4)
Asia (476)
Australia (25)
California (115)
Canada (23)
China (12)
Colorado (2)
Connecticut (2)
Delaware (21)
Europe (1128)
Florida (21)
Georgia (4)
Illinois (8)
India (1)
Indiana (19)
Iowa (1)
Japan (10)
Kansas (5)
Maryland (19)
Massachusetts (78)
Michigan (5)
Minnesota (3)
Missouri (2)
New Jersey (91)
New York (44)
North Carolina (14)
Northern California (70)
Ohio (2)
Pennsylvania (29)
South America (6)
Southern California (31)
Tennessee (1)
Texas (18)
Utah (5)
Virginia (2)
Washington State (10)
Wisconsin (1)
6,326 Results for "%E2%80%9D".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Encora Therapeutics’ Abstract at 2025 American Academy of Neurology (AAN) Annual Meeting Selected for Merit as “Abstract of Distinction”
April 14, 2025
·
2 min read
Press Releases
AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial
March 31, 2025
·
7 min read
Press Releases
ABIONYX Pharma, winner of the France 2030 Plan’s “i-Démo” call for projects, awarded €8.7 million from the French government to fight against Sepsis, the 3rd leading cause of death worldwide
February 20, 2025
·
1 min read
Press Releases
New Study in the Scientific Journal “Cancer Cell” Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses
April 9, 2025
·
5 min read
Press Releases
NexThera Completes First Patient Enrollment in U.S. Clinical Trial for ‘NT-101,’ an Eye Drop Treatment for Wet AMD
April 9, 2025
·
2 min read
Press Releases
Britecyte’s Adipose Tissue Allograft Earns “Safe to Proceed” Status from FDA
February 20, 2025
·
3 min read
Press Releases
MAIA Biotechnology Receives USAN Council Approval for “Ateganosine” as Nonproprietary Name for Anticancer Agent THIO
March 20, 2025
·
4 min read
Press Releases
TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model”
March 6, 2025
·
3 min read
Press Releases
Topline Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in Patients with Early Alzheimer’s Disease Carrying Two Copies of APOE4 Gene
April 10, 2025
·
13 min read
Press Releases
PESG Report: Silexion Therapeutics’ Breakthrough Data Shows SIL204’s impact on both Primary Tumors & Metastasis – Signaling a Potential Paradigm Shift in Cancer Treatment
March 17, 2025
·
4 min read
1 of 633
Next
